Read full plan here
Vision
By 2025, Canada will double the size of the health and biosciences sector and become a top-three global hub by: leveraging and advancing innovative technologies; attracting and retaining capital, skills and talent; and ensuring a vibrant ecosystem that will unleash the full potential of the sector and lead to improved health outcomes.
Business Wire National BioTech News
- New Microbiology and Chemistry Laboratory Gets Accredited under ISO/IEC 17025:2017
- Alpha Cancer Technologies Presents New Data from ACT-903, an AFP-Maytansine Conjugate, in Online Publication at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
- Kardium Announces First US Procedures in PULSAR Study of Globe® Pulsed Field System
- LinusBio Bucks Market Slowdown, Secures Additional $8M in A2 Funding with Increased Valuation
- Cybin Announces US$30M Common Stock Purchase Agreement from Lincoln Park Capital Fund
- Alpha Cognition Announces First Quarter 2023 Results and Provides Corporate Update
- Alpha Cognition Launches $6.5 Million Private Placement
- IPA's Subsidiary, BioStrand, Solves the Information Integration Dilemma (IID) for Systems Biology
- Enveric Biosciences Announces Poster Presentation at Canadian Neuroscience Meeting 2023
- BRUKINSA® Approved in Canada for the Treatment of Chronic Lymphocytic Leukemia